Hostname: page-component-74656f9884-j7cmm Total loading time: 0 Render date: 2026-11-09T14:56:03.885Z Has data issue: false hasContentIssue false

Receptors for growth and development of Schistosoma mansoni

Published online by Cambridge University Press:  14 February 2025

Iman F. Abou-El-Naga*
Affiliation:
Medical Parasitology Department, Faculty of Medicine, Alexandria University, Egypt
*
Corresponding author: Iman F. Abou-El-Naga; Email: eman.abuelnaga@alexmed.edu.eg
Rights & Permissions [Opens in a new window]

Abstract

The growth and development of schistosomes are tightly regulated by various receptors throughout their life cycle. Each stage of the parasite inhabits a distinct habitat and responds to different factors that drive its growth and development. With two hosts involved in its life cycle (mammalian and snail), the parasite must go through additional free-living stages to transition between them. Moreover, communication between male and female worms is essential for the maturation of females. The ability of adult schistosomes to survive in human hosts for up to thirty years demonstrates their capacity to efficiently utilize host nutrients for metabolic processes and growth. In Schistosoma mansoni, receptors mediate the utilization of growth factors derived from both the parasite itself and the host. Nuclear receptors, in particular, collaborate with other proteins to regulate the expression of genes essential for various developmental functions. Receptors also play a pivotal role in RNA export, which is crucial for the parasite development. Additionally, neurotransmitter receptors are essential for the growth and development of larval stages. This review aims to elucidate the mechanisms by which these receptors regulate cell proliferation, differentiation, and maturation throughout the parasite life cycle. Understanding these processes could provide insights into the role of receptors in Schistosoma mansoni development and potentially lead to innovative therapeutic strategies to combat human schistosomiasis.

Information

Type
Review Article
Copyright
© The Author(s), 2025. Published by Cambridge University Press
Figure 0

Table 1. Growth factor receptors

Figure 1

Table 2. Nuclear hormone receptors and nuclear transport receptors

Figure 2

Figure 1. (a) Schematic diagram of a typical nuclear receptor (NR) consisting of A/B, C, D, E, F domains and N and C terminals. The A/B domain includes the activation function 1 (AF-1), C domain is a DNA binding domain (DBD), D domain is a hinge region, E domain contains a ligand binding domain (LBD), and AF-2. (b) Schematic diagram for atypical NRs of S. mansoni containing two DBDs and a single LBD.

Figure 3

Figure 2. Schematic diagram of S. mansoni RNAs transport by XPO5, XPOT, and XPO1. XPO5 (Smp_152800) binds to pre-miRNA, and XPOT (Smp_137650) binds to tRNA directly in a RanGTP dependent manner. Once RNA proteins are exported to the cytoplasm, the RanGTP is converted to GDP resulting in the release of pre-miRNA from the XPO5 and tRNA from the XPOT. Nuclear export of snRNA, rRNA, and mRNA by XPO1 (Smp_124820) requires the cap-binding complex (CBC) protein, a nuclear export signal (NES) containing adaptor protein and RanGTP. The complex transits to the cytoplasm through the nuclear pore complex (NPC) and releases the cargo protein upon the hydrolysis of RanGTP.

Figure 4

Table 3. Neurotransmitter receptors

Figure 5

Figure 3. (a) Schematic diagram of the expected S. mansoni metabotropic glutamate receptor (SmGluR) (Smp_128940) comprising a large N-terminal extracellular ligand binding domain (LBD), a seven-transmembrane (7-TM) anchoring segment, and a C-terminal intracellular domain (ICD) of varying lengths. The LBD is connected to the 7-TM region by a short cysteine-rich domain (CRD). (b)S. mansoni glutamate-binding protein (SmGBP) (Smp_052660) receptor has a conserved ligand binding domain (LBD) but is missing the cysteine-rich domain, the characteristic 7-TM region, and intracellular domain.